22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology. 

Latest News

22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022

View Press Release View All

22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch
View Press Release

22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
View Press Release

22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes
View Press Release

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today